Ventripoint Diagnostics Ltd. announced that Justin Leushner has been appointed the President of Ventripoint. Desmond Hirson, as the Chief Technology Officer, will be responsible for the commercialization of the next-generation VMS+ system and will lead the efforts as the Company embarks on new technological advancements in medical imaging. As part of the restructuring, Dr. Alvira Macanovic is now Senior Director, Operations, Regulatory Affairs & Quality Assurance and Jessica Naman is the Director of Marketing. Mr. Leushner has had an extensive and diverse business career in the life sciences and biotechnology industries. He developed a national molecular diagnostics program for MDS Inc., Canada's largest life science's company, and served as a business analyst and portfolio advisor to the Canadian Medical Discoveries Fund. In 2004, Justin co-founded Sernova Corp., currently traded on the Toronto Stock Exchange.